Mykronor (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Mykronor, is a sympathomimetic amine presented as an injectable solution for intravenous use. It is employed in critical care to treat acute hypotension, septic shock, cardiogenic shock and cardiac arrest in hospitalized patients requiring rapid blood pressure support.

GNH USA supplies Mykronor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and intensive care units worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution in EU and other markets.

Mykronor, a vasopressor acting on the adrenergic system, is indicated for several acute shock states.

Acute hypotension: raises systemic blood pressure to maintain organ perfusion. Septic shock: restores vascular tone and supports circulation in severe infection. Cardiogenic shock: improves cardiac output and systemic perfusion when the heart fails to pump effectively. Cardiac arrest: provides vasoconstrictive support during resuscitation efforts.

Noradrenaline may produce a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Hypertension: excessive rise in blood pressure. - Headache: pressure‑type head pain.

Serious or Rare Side Effects: - Myocardial ischemia: reduced blood flow to heart muscle. - Cardiac arrest: sudden loss of heart function. - Tissue necrosis at infusion site: local tissue death due to extravasation.

When using Mykronor, clinicians should observe several safety precautions to minimize risks.

Cardiovascular monitoring: continuous blood pressure and heart‑rate monitoring is required. Titration by experienced staff: dose should be adjusted gradually under specialist supervision. Contraindication in uncontrolled hypertension: avoid use in patients with severely elevated baseline pressure. Caution in myocardial ischemia: use only if benefits outweigh risk of reduced coronary perfusion. Adjust in renal or hepatic impairment: monitor plasma levels and organ function closely. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline can interact with other medicines, influencing its pressor effect or causing adverse events.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effect leading to severe hypertension. - Other vasopressors (e.g., epinephrine): may cause excessive vasoconstriction.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt the desired increase in cardiac output. - Calcium channel blockers: can enhance hypotensive episodes if dose is reduced. - Diuretics: may potentiate volume depletion and affect blood pressure response. - General anesthetics: may alter hemodynamic stability during surgery.